{"nct_id":"NCT05222555","title":"Safety and Pharmacokinetics Study of a Modified Tafasitamab IV Dosing Regimen Combined With Lenalidomide in R-R DLBCL Patients","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-07","start_date":"2022-07-19","start_date_type":"ACTUAL","primary_completion_date":"2024-07-17","primary_completion_date_type":"ACTUAL","completion_date":"2027-11-30","completion_date_type":"ESTIMATED","phases":["PHASE1","PHASE2"],"tickers":["INCY"]}